Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 10 Mar 2023
Today's top stories include: Nine-year cap to complete MBBS, elective-based credits offered in NMC letter Students enrolled in...
Read Full NewsA retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.
For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.
Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.
Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.
1.
Higher Risk of Kidney Cancer Recurrence After Ablative Therapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most
4.
To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.
5.
NIH research cuts leave cancer patient facing hard choice
1.
The Life-Saving Powers of Anemia: How to Combat the Disease.
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
4.
Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide
5.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part VI
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge